Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Cycling News
Cycling News
Sport
Laura Weislo

Greek track sprinter positive in re-analysis of 2016 Olympics samples

Christos Volikakis on the podium of the Men's Scratch Race during the 2019 UCI Track Cycling World Cup in Hong Kong.

The UCI announced that it has provisionally suspended Greek track sprinter Christos Volikákis, 36, after he tested positive for an experimental drug, Ligandrol (LGD-4033), in the re-analysis of doping controls taken at the 2016 Olympic Games in Rio de Janeiro, Brazil.

Ligandrol is a selective androgen receptor modulator (SARM), a class of drugs that activate androgen receptors, providing the same benefits as anabolic steroids without the side effects on reproductive organs. SARMs are prohibited substances under class S1.2 (Other Anabolic Agents) of the Prohibited List.

Volikákis' only event of the 2016 Olympic Games was the men's keirin, where he finished in12th place behind gold medalist Jason Kenny (Great Britain). 

His doping control sample collected on the same day, August 16, 2016, was put into storage under the World Anti-Doping Code which, since 2004, has allowed for samples to be re-tested using newly developed methods.

The rule was implemented in the wake of the era of widespread EPO abuse and the evolution of growth hormones and other drugs that were difficult to detect or had short windows of detection. It allowed for the development of detection methods for emerging doping products and was thought to deter doping.

Samples from the 2008 Beijing Olympics were re-tested for a newer form of EPO, CERA, 

The International Testing Agency, which performs testing for the UCI and many other sports, launched its re-analysis of the Rio samples on behalf of the International Olympic Committee (IOC) in December in a two-phase approach. The top priority was to first test samples from athletes who are still active and may be selected for the 2024 Olympics in Paris. A second phase will include athletes who are no longer competing.

Once an athlete like Volikákis tests positive, their case follows the normal anti-doping adjudication protocols. He has the right to request an analysis of his B sample but is not allowed to compete until his case is concluded.

Volikákis has continued to compete since 2016, changing over to endurance events after Rio. He won the scratch race at the 2019 World Cup in Cambridge. However, the country has so far failed to amass enough points to qualify for the Paris Olympics in men's track cycling.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.